SCHEMBL13502074

SCHEMBL13502074

Cc1cc2c(cc1/N=C/c1ccccc1)c1cc(/N=C/c3ccccc3)c(C)cc1p2-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ G6PD P11413 2/20 0.36
▸ MAPT P10636 5/20 0.35
▸ KMT2A Q03164 5/20 0.35
▸ THRB P10828 2/20 0.35
▸ PKM P14618 2/20 0.35
▸ ALOX15 P16050 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ ALDH1A1 P00352 7/20 0.35
▸ KDM4E B2RXH2 6/20 0.35
▸ HPGD P15428 6/20 0.35
▸ LMNA P02545 4/20 0.35
▸ MEN1 O00255 4/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ HTT P42858 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13672087 0.74 HPGD (0.41) G6PDMAPTKMT2ATHRBPKM
SCHEMBL13342819 0.74 ALDH1A1 (0.40) G6PDMAPTKMT2ATHRBPKM
SCHEMBL13502072 0.73 ALDH1A1 (0.35) MAPTKMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL13502073 0.73 TTR (0.41) MAPTCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL13502049 0.69 CD44 (0.33) MAPTKMT2ATHRBPKMCYP3A4
SCHEMBL13502048 0.69 ACHE (0.35) KMT2AALDH1A1MEN1TSHRHSD17B10
SCHEMBL13815407 0.69 ALDH1A1 (0.38) G6PDMAPTKMT2ATHRBPKM
SCHEMBL7636431 0.68 CYP2C9 (0.52) MAPTKMT2APKMCYP2C9ALDH1A1
SCHEMBL5074324 0.68 CYP2C9 (0.52) MAPTKMT2APKMCYP2C9ALDH1A1
SCHEMBL13502127 0.68 ALDH1A1 (0.37) G6PDMAPTKMT2ATHRBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662478-B2 Polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-16 — — US disclosed
US-7662478-B2 Polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-16 — — US disclosed
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED 2008-05-01 — — US disclosed
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED 2008-05-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME CRY1, ARCN1, CORO1A G6PD 1413/4885MAPT 2640/4885KMT2A 3822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback